Trial Profile

A pharmacokinetics study to demonstrated the bioequivalence of JR-051.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 25 Jun 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Agalsidase beta (Primary)
Indications Fabry's disease
Focus First in man; Pharmacokinetics

Most Recent Events

17 Jun 2020 Results presented in a JCR Pharmaceuticals media release.
01 May 2020 Results published in the electronic edition of Molecular Genetics and Metabolism, the official journal of Society for Inherited Metabolic Disorders.
05 Oct 2017 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com